Cellebrite director awarded 15,190 RSUs

A Cellebrite DI Ltd. director received a 15,190-RSU equity award vesting in 2027, increasing her direct share holdings.

Rhea-AI Filing Summary

Cellebrite DI Ltd. (symbol: CLBT) is the issuer of record for a Form 4 filing submitted to the SEC. Baudot-Trajtenberg Nadine reported acquisition or exercise transactions in this Form 4 filing.

Cellebrite DI Ltd. (CLBT) reported that director Nadine Baudot-Trajtenberg received an equity award of 15,190 restricted share units (RSUs) on September 17, 2026. The RSUs will vest on September 17, 2027, with each RSU settling into one Ordinary Share upon vesting. Following this award, she holds 50,744 Ordinary Shares directly.

Insider Trade Summary

Grant/Award: 15,190 shares

Grant/Award 1 txn

Insider Baudot-Trajtenberg Nadine

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary shares, par value NIS 0.00001 F1	15,190	$0.00	$0.00

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 50,744 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Key Figures

RSUs awarded: 15,190 units Price per share: $0.00 per share Shares held after transaction: 50,744 shares +1 more

4 metrics

RSUs awarded 15,190 units Restricted share units granted to director on September 17, 2026

Price per share $0.00 per share Reported grant price for RSU-related Ordinary Shares

Shares held after transaction 50,744 shares Director’s direct Ordinary Share holdings following the award

RSU vesting date September 17, 2027 Date when the 15,190 RSUs are scheduled to vest

Key Terms

restricted share units ("RSUs"), contingent right, Ordinary Share

3 terms

restricted share units ("RSUs") financial

"Represents an award of restricted share units ("RSUs") that will vest"

contingent right financial

"Each RSU represents a contingent right to receive one Ordinary Share"

Ordinary Share financial

"to receive one Ordinary Share of the Issuer upon settlement"

An ordinary share is a unit of ownership in a company that gives the holder a stake in its profits and usually the right to vote on key decisions. Think of it like a slice of a pizza where each slice entitles you to a portion of what’s left after bills are paid; value can rise or fall with the business and may pay dividends, so it matters to investors for income, growth and control.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cellebrite DI Ltd. (CLBT) disclose?

Cellebrite DI Ltd. disclosed that director Nadine Baudot-Trajtenberg received an award of 15,190 restricted share units (RSUs) on September 17, 2026, each representing a contingent right to receive one Ordinary Share upon settlement.

When do the new RSUs for CLBT’s director vest?

The 15,190 RSUs awarded to Cellebrite DI Ltd. director Nadine Baudot-Trajtenberg will vest on September 17, 2027. Upon settlement, each vested RSU converts into one Ordinary Share of Cellebrite DI Ltd.

How many CLBT shares does the director hold after this RSU grant?

After the RSU grant, director Nadine Baudot-Trajtenberg holds 50,744 Ordinary Shares of Cellebrite DI Ltd. directly. This figure reflects her reported direct ownership immediately following the September 17, 2026 award.

Was the CLBT director’s RSU award a market purchase or a grant?

The transaction was reported as a grant or award, not a market purchase. The Form 4 shows an acquisition of 15,190 Ordinary Shares at a stated price of $0.00 per share, consistent with a restricted share unit equity award.

Is the CLBT director’s RSU award under a Rule 10b5-1 trading plan?

No Rule 10b5-1 trading plan is reported. The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan, and the single transaction is presented as an equity award of RSUs vesting in 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 08:05 AM Accepted by SEC EDGAR 09/17/2026 - 08:05 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baudot-Trajtenberg Nadine

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares, par value NIS 0.00001	09/17/2026		A		15,190(1)	A	$0	50,744	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Remarks:

	/s/ Nadine Baudot-Trajtenberg	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)